Stock Information
Cullinan Therapeutics Inc (CGEM)
Ticker Symbol: CGEM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $625,597,800.00 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.6801
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -41.58%
Latest News
-
Will Cullinan Therapeutics (NASDAQ:CGEM) Spend Its Cash Wisely?
Wed, Dec 17, 2025 4:17 PM
-
Cullinan Therapeutics (CGEM) Jumps on Promising Phase 1 Data for CLN-049 in AML, Showing Strong Response Rates
Tue, Dec 16, 2025 4:10 AM
Key Financials
Financial data not available
